<DOC>
	<DOCNO>NCT00380588</DOCNO>
	<brief_summary>To investigate efficacy safety gemcitabine combine cisplatin gemcitabine alone comparison patient advance biliary tract cancer</brief_summary>
	<brief_title>Randomized Phase 2 Study With Gemcitabine Alone Combination Therapy Patients With Advanced Biliary Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histological cytological diagnosis biliary tract cancer Measurable disease must least one lesion Chemotherapyna√Øve Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Estimated life expectancy le 3 month radiological clinical evidence pulmonary fibrosis interstitial pneumonia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>